Michael J. Yang - Net Worth and Insider Trading
Michael J. Yang Net Worth
The estimated net worth of Michael J. Yang is at least $266,115 dollars as of 2024-11-13. Michael J. Yang is the EVP and CCO of ACADIA Pharmaceuticals Inc and owns about 8,059 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $144,578. Michael J. Yang is also the Director of Pacira BioSciences Inc and owns about 7,230 shares of Pacira BioSciences Inc (PCRX) stock worth over $121,536. Details can be seen in Michael J. Yang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael J. Yang has not made any transactions after 2024-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael J. Yang
Michael J. Yang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael J. Yang owns 3 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) , Akcea Therapeutics Inc (AKCA) , and Pacira BioSciences Inc (PCRX) .
Click here to see the complete history of Michael J. Yang’s form 4 insider trades.
Insider Ownership Summary of Michael J. Yang
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2021-01-06 | EVP AND CCO |
| AKCA | Akcea Therapeutics Inc | 2020-10-12 | director |
| PCRX | Pacira BioSciences Inc | 2024-08-14 | director |
Michael J. Yang Latest Holdings Summary
Michael J. Yang currently owns a total of 2 stocks. Among these stocks, Michael J. Yang owns 8,059 shares of ACADIA Pharmaceuticals Inc (ACAD) as of January 6, 2021, with a value of $144,578 and a weighting of 54.33%. Michael J. Yang also owns 7,230 shares of Pacira BioSciences Inc (PCRX) as of August 14, 2024, with a value of $121,536 and a weighting of 45.67%.
Latest Holdings of Michael J. Yang
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2021-01-06 | 8,059 | 17.94 | 144,578 |
| PCRX | Pacira BioSciences Inc | 2024-08-14 | 7,230 | 16.81 | 121,536 |
Holding Weightings of Michael J. Yang
Michael J. Yang Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael J. Yang has made a total of 6 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 1,120 shares on January 6, 2021, which brought Michael J. Yang around $59,741.
According to the SEC Form 4 filings, Michael J. Yang has made a total of 1 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pacira BioSciences Inc is the acquisition of 2,000 shares on August 14, 2024, which cost Michael J. Yang around $25,800.
Insider Trading History of Michael J. Yang
- 1
Michael J. Yang Trading Performance
GuruFocus tracks the stock performance after each of Michael J. Yang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael J. Yang is 38.25%. GuruFocus also compares Michael J. Yang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael J. Yang within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael J. Yang's insider trading performs compared to the benchmark.
Performance of Michael J. Yang
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.13 |  | | | | |
| Relative Return to S&P 500(%) | 2 | | | | | |
Michael J. Yang Ownership Network
Ownership Network List of Michael J. Yang
Ownership Network Relation of Michael J. Yang
Michael J. Yang Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
Michael J. Yang is the EVP AND CCO of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , director & PRESIDENT AND CEO Stephen Davis , and Chief Financial Officer Mark C. Schneyer .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, Michael J. Yang made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 319,936 shares made by Stephen Davis , and a net sale of 41,903 shares made by Brendan Teehan .
In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 455,345 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 441,177 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
Michael J. Yang Mailing Address
Above is the net worth, insider trading, and ownership report for Michael J. Yang. You might contact Michael J. Yang via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
